Elanco Animal Health Inc (NYSE:ELAN) shares traded -2.19% lower at $10.27 on Wall Street last session.
ELAN stock price is now -12.86% away from the 50-day moving average and -6.24% away from the 200-day moving average. The market capitalization of the company currently stands at $5.06B.
With the price target maintained at $14, Barclays recently Upgraded its rating from Equal Weight to Overweight for Elanco Animal Health Inc (NYSE: ELAN).
In other news, HOOVER R DAVID, Director bought 5,000 shares of the company’s stock on Mar 14. The stock was bought for $47,750 at an average price of $9.55. Upon completion of the transaction, the Director now directly owns 165,000 shares in the company, valued at $1.69 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 13, Director HOOVER R DAVID bought 5,000 shares of the business’s stock. A total of $47,288 was incurred on buying the stock at an average price of $9.46. This leaves the insider owning 160,000 shares of the company worth $1.64 million. Insiders disposed of 402,517 shares of company stock worth roughly $4.13 million over the past 1 year. A total of 0.60% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in ELAN stock. A new stake in Elanco Animal Health Inc shares was purchased by HOLOCENE ADVISORS, LP during the first quarter worth $51,042,000. H PARTNERS MANAGEMENT, LLC invested $35,175,000 in shares of ELAN during the first quarter. In the first quarter, POINT72 ASSET MANAGEMENT, L.P. acquired a new stake in Elanco Animal Health Inc valued at approximately $32,371,000. PRIVATE MANAGEMENT GROUP INC acquired a new stake in ELAN for approximately $9,865,000. WOODLINE PARTNERS LP purchased a new stake in ELAN valued at around $7,290,000 in the second quarter. In total, there are 583 active investors with 98.19% ownership of the company’s stock.
Elanco Animal Health Inc (NYSE: ELAN) opened at $10.55 on Wednesday. During the past 12 months, Elanco Animal Health Inc has had a low of $7.88 and a high of $14.69. As of last week, the company has a debt-to-equity ratio of 0.82, a current ratio of 2.84, and a quick ratio of 1.53. The fifty day moving average price for ELAN is $11.76 and a two-hundred day moving average price translates $10.94 for the stock.
The latest earnings results from Elanco Animal Health Inc (NYSE: ELAN) was released for Jun, 2023. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at $0.18, beating analysts’ expectations of $0.05 by 0.13. This compares to -$0.02 EPS in the same period last year. The net profit margin was -2.24% and return on equity was -1.33% for ELAN. The company reported revenue of $1.06 billion for the quarter, compared to $1.18 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -10.04 percent. For the current quarter, analysts expect ELAN to generate $1.04B in revenue.
